Study on the bioequivalence of two formulations of eplerenone in healthy volunteers under fasting conditions: data from a single-center, randomized, single-dose, open-label, 2-way crossover bioequivalence study-Reference-Cited by-同舟云学术

Study on the bioequivalence of two formulations of eplerenone in healthy volunteers under fasting conditions: data from a single-center, randomized, single-dose, open-label, 2-way crossover bioequivalence study

Published:2011-11-28 Issue:03 Volume:61 Page:153-159
ISSN:0004-4172
Container-title:Arzneimittelforschung
language:en
Short-container-title:Arzneimittelforschung

Author:

Almeida Susana¹²,Pedroso Pedro¹,Filipe Augusto¹,Pinho Catarina¹,Neves Rita¹,Jiménez Cintia³,Sicard Eric⁴,Lefebvre Marc⁴

Affiliation:

1. Medical Department

2. Department of Pharmacology and Therapeutics

3. Anapharm Europe S.L.

4. Algorithme Pharma Inc

Publisher

Georg Thieme Verlag KG

Subject

Drug Discovery

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0031-1296182.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eplerenone repurposing in management of chorioretinopathy: Mechanism, nanomedicine‐based delivery applications and future trends;British Journal of Clinical Pharmacology;2022-02-03

2. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: in-vitro optimization and ex-vivo assessment;Drug Delivery;2021-01-01

3. Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability;Pharmaceutics;2019-01-18

4. Process-related impurities of eplerenone: determination and characterisation by HPLC methods and Raman spectroscopy;Journal of Pharmaceutical and Biomedical Analysis;2018-09

5. Generic versus brand-name drugs used in cardiovascular diseases;European Journal of Epidemiology;2015-11-30